Sarcopenia. (2021)
- Record Type:
- Book
- Title:
- Sarcopenia. (2021)
- Main Title:
- Sarcopenia
- Further Information:
- Note: Edited by Alfonso J. Cruz-Jentoft, John E. Morley.
- Editors:
- Cruz-Jentoft, Alfonso J
Morley, John E - Contents:
- List of Contributors vii Preface xiii 1 Definitions of Sarcopenia 1; Alfonso J. Cruz‐Jentoft, Beatriz Montero‐Errasquin and John E. Morley 2 Epidemiology of Muscle Mass Loss with Age 11; Marjolein Visser 3 The Role of Mitochondria in Age‐Related Sarcopenia 19; Luigi Ferrucci, Marta Zampino, Paul Coen and Bret H. Goodpaster 4 Motor Unit Remodeling 35; Ben Kirk and Mathew Piasecki 5 Nutrition, Protein Turnover and Muscle Mass 45; St éphane Walrand, Christelle Guillet and Yves Boirie 6 Recognizing Persons at Risk for Sarcopenia 63; John E. Morley 7 Adverse Outcomes and Functional Consequences of Sarcopenia 71; Jean Woo 8 A Lifecourse Approach to Sarcopenia 77; Richard Dodds and Avan Aihie Sayer 9 Acute Sarcopenia 95; Beatrice Gasperini, Stefano Volpato and Antonio Cherubini 10 Sarcopenia, Frailty, and Intrinsic Capacity 115; Jurgen M. Bauer and Cornel Sieber 11 Osteosarcopenia 127; Ben Kirk, Jesse Zanker, Steven Phu and Gustavo Duque 12 Sarcopenic Obesity 147; Mauro Zamboni, Federica Macchi, Nicole Nori and Andrea P. Rossi 13 Sarcopenia and Cognitive Impairment 157; Liang‐Kung Chen 14 Sarcopenia and Other Chronic Organ Diseases 175; Hidenori Arai 15 Imaging of Skeletal Muscle 185; Thomas F. Lang 16 Measurements of Muscle Mass, Equations and Cut‐off Points 199; Marjolein Visser and Laura Schaap 17 Deuterated Creatine Dilution to Assess Muscle Mass (D3‐Cr Muscle Mass) in Humans: Methods, Early Results, and Future Directions 227; Peggy M. Cawthon and William J. Evans 18List of Contributors vii Preface xiii 1 Definitions of Sarcopenia 1; Alfonso J. Cruz‐Jentoft, Beatriz Montero‐Errasquin and John E. Morley 2 Epidemiology of Muscle Mass Loss with Age 11; Marjolein Visser 3 The Role of Mitochondria in Age‐Related Sarcopenia 19; Luigi Ferrucci, Marta Zampino, Paul Coen and Bret H. Goodpaster 4 Motor Unit Remodeling 35; Ben Kirk and Mathew Piasecki 5 Nutrition, Protein Turnover and Muscle Mass 45; St éphane Walrand, Christelle Guillet and Yves Boirie 6 Recognizing Persons at Risk for Sarcopenia 63; John E. Morley 7 Adverse Outcomes and Functional Consequences of Sarcopenia 71; Jean Woo 8 A Lifecourse Approach to Sarcopenia 77; Richard Dodds and Avan Aihie Sayer 9 Acute Sarcopenia 95; Beatrice Gasperini, Stefano Volpato and Antonio Cherubini 10 Sarcopenia, Frailty, and Intrinsic Capacity 115; Jurgen M. Bauer and Cornel Sieber 11 Osteosarcopenia 127; Ben Kirk, Jesse Zanker, Steven Phu and Gustavo Duque 12 Sarcopenic Obesity 147; Mauro Zamboni, Federica Macchi, Nicole Nori and Andrea P. Rossi 13 Sarcopenia and Cognitive Impairment 157; Liang‐Kung Chen 14 Sarcopenia and Other Chronic Organ Diseases 175; Hidenori Arai 15 Imaging of Skeletal Muscle 185; Thomas F. Lang 16 Measurements of Muscle Mass, Equations and Cut‐off Points 199; Marjolein Visser and Laura Schaap 17 Deuterated Creatine Dilution to Assess Muscle Mass (D3‐Cr Muscle Mass) in Humans: Methods, Early Results, and Future Directions 227; Peggy M. Cawthon and William J. Evans 18 Measurement of Muscle Strength and Power 239; Michael Drey, Sandra Helmers and J ürgen M. Bauer 19 Measurements of Physical Performance 253; Laura Orlandini, Yves Rolland and Matteo Cesari 20 Biomarkers for Physical Frailty and Sarcopenia: A “Two‐Body Problem” 271; Anna Picca, Riccardo Calvani and Emanuele Marzetti 21 Quality of Life and Sarcopenia 279; Charlotte Beaudart, Jean‐Yves Reginster, Olivier Bruy ère and Anton Geerinck 22 Exercise Interventions to Prevent and Improve Sarcopenia 305; Mark D. Peterson and Jose A. Serra 23 Nutritional Approaches to Treat Sarcopenia 335; Tommy Cederholm, Jurgen M. Bauer and Alfonso J. Cruz‐Jentoft 24 Beta‐hydroxy‐beta‐methylbutyrate (HMB) and Sarcopenia 355; Francesco Landi, Riccardo Calvani, Anna Picca and Emanuele Marzetti 25 The Future of Drug Treatments 367; Francesco Landi, Graziano Onder and Rolland Yves 26 Sarcopenia: Is It Preventable? 403; Stany Perkisas, Keliane Liberman, Ivan Bautmans and Maurits Vandewoude 27 Financial Impact of Sarcopenia 421; Kristina Norman 28 Sarcopenia Management for Clinicians 433; Renuka Visvanathan and Solomon Yu Index 441 … (more)
- Edition:
- Second edition
- Publisher Details:
- Chichester : Wiley Blackwell
- Publication Date:
- 2021
- Extent:
- 1 online resource
- Subjects:
- 612.67
Muscles -- Diseases
Aging -- Physiological aspects - Languages:
- English
- ISBNs:
- 9781119597902
- Related ISBNs:
- 9781119597872
- Notes:
- Note: Description based on CIP data; resource not viewed.
- Access Rights:
- Legal Deposit; Only available on premises controlled by the deposit library and to one user at any one time; The Legal Deposit Libraries (Non-Print Works) Regulations (UK).
- Access Usage:
- Restricted: Printing from this resource is governed by The Legal Deposit Libraries (Non-Print Works) Regulations (UK) and UK copyright law currently in force.
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library HMNTS - ELD.DS.641547
- Ingest File:
- 06_033.xml